Petter Cappelen Endresen

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

Timo Mäkikallio, Niels Ramsing Holm, Mitchell Lindsay et al. · The Lancet · 2016 · 758 citations · Full text

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +7

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

Niels Ramsing Holm, Timo Mäkikallio, Mitchell Lindsay et al. · The Lancet · 2019 · 424 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +10

A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F‐actin and DNA

Petter Cappelen Endresen, Per S. Prytz, Jarle Aarbakke · Cytometry · 1995 · 55 citations · Full text

Persistent changes in the immune system 4–10 years after ABMT

Tone Nordøy, Arne Kolstad, Petter Cappelen Endresen et al. · Bone Marrow Transplantation · 1999 · 29 citations

Clinical Immunology, Allergy, Immune Cell Development +11

Cell death initiated by 3-deazaadenosine in HL-60 cells is apoptosis and is partially inhibited by homocysteine

Petter Cappelen Endresen, Tor J. Eide, Jarle Aarbakke · Biochemical Pharmacology · 1993 · 23 citations

Biochemistry, Apoptosis, Autophagy +6